Chimeric antigen receptor T-cell therapy—CAR T for short—has been a major advance in treating blood cancers like leukemia and ...
In a demonstration that could help pave the way for gene therapies with fewer side effects, several human cell types have ...
Full enrollment of BLA-enabling trial complete, per prior guidance –– Topline NEXICART-2 Results Expected Q3 2026, followed by BLA submission ...
Sens. addressed "deeply concerning" potential for Iranian sleeper cells to unleash terror attacks on the US as hundreds entered under Biden.
The field of cancer immunology has undergone significant transformation over the past decade, reshaping our understanding of tumor–immune system ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results